Prolensa ophthalmic and Tofacitinib Extended-Release Tablets
Determining the interaction of Prolensa ophthalmic and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromfenac ophthalmic
Brand name: BromSite, Prolensa, Bromday, Xibrom
Synonyms: Prolensa (ophthalmic), Prolensa
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Prolensa ophthalmic-Tofacitinib Tablets
- Prolensa ophthalmic-Tofranil
- Prolensa ophthalmic-Tofranil injection
- Prolensa ophthalmic-Tofranil-PM
- Prolensa ophthalmic-Tol-Tab
- Prolensa ophthalmic-Tolazamide
- Tofacitinib Extended-Release Tablets-Proleukin
- Tofacitinib Extended-Release Tablets-Prolex D
- Tofacitinib Extended-Release Tablets-Prolia
- Tofacitinib Extended-Release Tablets-Prolida Patch
- Tofacitinib Extended-Release Tablets-Prolixin
- Tofacitinib Extended-Release Tablets-Prolixin Decanoate